Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$456M |
| 2 |
SW
Smurfit Westrock
SW
|
+$403M |
| 3 |
Walt Disney
DIS
|
+$391M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$345M |
| 5 |
EPAM Systems
EPAM
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$671M |
| 2 |
Nike
NKE
|
+$557M |
| 3 |
Microchip Technology
MCHP
|
+$544M |
| 4 |
Visa
V
|
+$535M |
| 5 |
Becton Dickinson
BDX
|
+$487M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.06% |
| 2 | Financials | 10.52% |
| 3 | Healthcare | 9.63% |
| 4 | Industrials | 8.45% |
| 5 | Consumer Discretionary | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Yum China
YUMC
$16.3B
| $11.9M | ﹤0.01% |
264,782
+2,820
| +1% | +$93.9K |
|
1627
Arcosa
ACA
$7.11B
| $11.9M | ﹤0.01% |
125,587
-11,716
| -9% | -$1.02M |
|
1628
Sunrun
RUN
$2.46B
| $11.8M | ﹤0.01% |
655,117
-55,455
| -8% | -$985K |
|
|
CADE
1629
DELISTED
Cadence Bank
CADE
| $11.8M | ﹤0.01% |
369,939
-19,078
| -5% | -$591K |
|
1630
STMicroelectronics
STM
$50B
| $11.8M | ﹤0.01% |
396,580
+28,620
| +8% | +$946K |
|
1631
Universal Health Services
UHS
$10.5B
| $11.8M | ﹤0.01% |
51,561
-6,431
| -11% | -$1.39M |
|
1632
Acadia Pharmaceuticals
ACAD
$5.03B
| $11.7M | ﹤0.01% |
763,874
+21,228
| +3% | +$354K |
|
1633
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$668M
| $11.7M | ﹤0.01% |
213,001
-1,249
| -0.6% | -$68.2K |
|
1634
Toro Company
TTC
$9.49B
| $11.7M | ﹤0.01% |
134,971
-64,484
| -32% | -$5.8M |
|
1635
Innovative Industrial Properties
IIPR
$1.72B
| $11.7M | ﹤0.01% |
86,925
-8,687
| -9% | -$1.06M |
|
1636
BCE
BCE
$21.2B
| $11.7M | ﹤0.01% |
334,202
-720,639
| -68% | -$24.6M |
|
1637
Vale
VALE
$62.6B
| $11.7M | ﹤0.01% |
998,538
+71,293
| +8% | +$764K |
|
1638
Magnite
MGNI
$3.55B
| $11.6M | ﹤0.01% |
839,236
+19,965
| +2% | +$272K |
|
1639
US Physical Therapy
USPH
$1.22B
| $11.6M | ﹤0.01% |
136,728
-8,799
| -6% | -$781K |
|
1640
Cohen & Steers Quality Income Realty Fund
RQI
$1.69B
| $11.6M | ﹤0.01% |
815,279
+1,264
| +0.2% | +$16.4K |
|
1641
iShares Core Moderate Allocation ETF
AOM
$1.78B
| $11.5M | ﹤0.01% |
256,058
+11,485
| +5% | +$504K |
|
1642
First Horizon
FHN
$12.1B
| $11.5M | ﹤0.01% |
740,777
-74,304
| -9% | -$1.18M |
|
1643
BBB Foods
TBBB
$4.92B
| $11.5M | ﹤0.01% |
383,577
-74,822
| -16% | -$2.1M |
|
1644
Vail Resorts
MTN
$5.3B
| $11.5M | ﹤0.01% |
65,984
-4,111
| -6% | -$735K |
|
1645
Yeti Holdings
YETI
$3.95B
| $11.5M | ﹤0.01% |
279,891
-13,696
| -5% | -$537K |
|
1646
TaskUs
TASK
$669M
| $11.5M | ﹤0.01% |
887,949
+40,086
| +5% | +$568K |
|
1647
Campbell Soup
CPB
$6.87B
| $11.5M | ﹤0.01% |
234,395
-54,165
| -19% | -$2.64M |
|
1648
BridgeBio Pharma
BBIO
$16.5B
| $11.5M | ﹤0.01% |
450,381
+415,606
| +1,195% | +$10.9M |
|
1649
InvenTrust Properties
IVT
$2.59B
| $11.5M | ﹤0.01% |
403,856
+291,551
| +260% | +$8.09M |
|
1650
Planet Fitness
PLNT
$3.96B
| $11.4M | ﹤0.01% |
140,888
-429,297
| -75% | -$33.6M |
|
Similar funds
Ameriprise's Q3 2024 Portfolio in Review
As of Q3 2024, Ameriprise held 4,064 positions worth $390B, up 5.5% from $370B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q3 2024 filing shows 197 new, 1,617 increased, 1,938 reduced and 141 closed positions. Its largest new stake was Smurfit Westrock: 8,854,270 shares worth $438M. The largest sale was Apple, an estimated $671M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q3 2024 buy was Smurfit Westrock: 8,854,270 shares worth $438M.
- Ameriprise added most to UnitedHealth in Q3 2024, an estimated $456M increase.
- Ameriprise's biggest Q3 2024 reduction was Apple, cutting an estimated $671M.
- Ameriprise fully exited Cerevel Therapeutics Holdings, Inc. Common Stock in Q3 2024, selling an estimated $55.1M.
- Ameriprise's ten largest holdings make up 19% of its $390B portfolio in Q3 2024.
- Ameriprise opened 197 new positions and closed 141 in Q3 2024.
- Ameriprise's portfolio value rose 5.5% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q3 2024, filed 14 Nov 2024.